ProGen Search
Intelligence Vault
Talent

Leadership and Compensation Benchmark: Preview Report

A free preview of how ProGen's leadership and compensation benchmark is built, down to a single executive row. It reads executive pay, leadership-team structure, the terms offered to incoming officers and employer-posted pay ranges across radiopharma, ADC, cell and gene therapy, CDMO and CRO, company by company, so the peer set is the one the buyer chooses. Results are reserved for buyers.

PDF8 pagesPublished November 2026Free

Built to order · Research cut-off: 18 November 2026

What this report answers

  • What do comparable companies pay their chief executive and each named officer, in base salary, bonus and equity?
  • How do pay levels and pay mix change from early clinical to commercial?
  • Which leadership seats exist at each stage, and which functions sit on the executive team?
  • What does it take to bring a leader in: route, base, target bonus, sign-on cash and inducement equity?
  • Where do employer-posted ranges sit for directors, senior directors and vice presidents?

235 listed companies

Screened across five modalities and tagged by modality, stage and listing.

151 officer appointments

At 72 companies since January 2025, each read term by term.

What the analysis establishes

Four questions, four kinds of disclosure

Pay is read from proxy statements, pay-versus-performance tables and annual remuneration reports; structure from executive-officer disclosures; new-hire terms from officer appointment filings; and hiring signals from the pay ranges employers post. Each is joined company by company for the same year.

Executive pay, row by row

1,061 executive pay records from 115 US-listed companies, plus 147 executive disclosures from 44 companies reporting in 12 other countries. Every row carries base salary, bonus target where stated, cash incentive paid, equity granted, total and, for the chief executive, compensation actually paid where disclosed. The preview shows one row field by field, with values withheld.

Leadership structure and new hires

323 executive officers across 74 leadership teams, classified by function and stage, and 151 officer appointments at 72 companies since January 2025, each read for route, base salary, target bonus, sign-on cash, inducement equity and severance.

Below the executive team

387 employer-posted pay ranges for leadership and technical roles at 66 employers across all five modalities, from manager to vice president, laid out by level and function family.

Built to your peer set

Each benchmark is scoped to the companies and roles you choose: a portfolio, a sector or a list of named competitors, widened with private companies through ProGen's search work, and quoted on request.

About this intelligence

Sources include company proxy statements, annual and remuneration reports, appointment filings and employer job postings. Other sources are proprietary ProGen intelligence sources. 6,471 facts from 726 public documents, each linked to its source. Evidence is current to 18 November 2026.

Investors benchmarking leadership across a portfolio or before an investment. Boards and remuneration committees setting packages. Leadership and HR teams planning a build-out. Corporate development teams assessing a target's team.

Contents

  • Why a leadership and compensation benchmark
  • The questions it answers
  • How the benchmark is built
  • Coverage by modality
  • Outside the US
  • Pay: one row, field by field
  • What each pay table is read by
  • Which seats exist
  • What it takes to bring a leader in
  • Below the executive team: posted ranges
  • The evidence base
  • What a buyer receives

Modalities covered

Radiopharma, ADC and conjugates, Cell and gene therapy, CDMO, CRO

Free report

The full 8-page briefing is free. Tell us where to send it and it downloads immediately.

Related analysis